CryoTherapeutics is an early-stage European innovator that has established its operations in Loncin (Liège), Belgium. The company is in the process of developing a novel intracoronary catheter system delivering cryoenergy to the coronary arteries. The system aims to treat high-risk atherosclerotic plaque in patients (at high risk of) suffering a heart attack.

CryoTherapeutics has implemented an employee personal development policy, encouraging continuous education and promoting autonomy and empowerment. We believe a good work – life balance is key to ensuring the wellbeing of our employees.



CryoTherapeutics closes new €12.3 million financing round.

Find out more